ClinVar Miner

Submissions for variant NM_030662.4(MAP2K2):c.1162C>T (p.Arg388Trp) (rs144383241)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen RASopathy Variant Curation Expert Panel RCV000200611 SCV000616547 benign Rasopathy 2017-05-09 reviewed by expert panel curation The filtering allele frequency of the c.1162C>T (p.Arg388Trp) variant in the MAP2K2 gene is 0.125% for African chromosomes by the Exome Aggregation Consortium (25/2788 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). Additional case-level data available: SCV000204180.4; SCV000252871.4.
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000154509 SCV000204180 likely benign not specified 2015-06-26 criteria provided, single submitter clinical testing p.Arg388Trp in exon 11 of MAP2K2: This variant is not expected to have clinical significance because it has been identified in 0.9% (25/2788) of African chromos omes by the Exome Aggregation Consortium (ExAC,; dbSNP rs144383241).
Invitae RCV000200611 SCV000252871 benign Rasopathy 2020-11-24 criteria provided, single submitter clinical testing
Eurofins NTD, LLC RCV000154509 SCV000337012 benign not specified 2015-12-08 criteria provided, single submitter clinical testing
GeneDx RCV000680296 SCV000513533 benign not provided 2016-06-03 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Baylor Genetics RCV001334284 SCV001527084 uncertain significance Cardiofaciocutaneous syndrome 4 2018-08-31 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Service de Génétique Moléculaire,Hôpital Robert Debré RCV000824952 SCV000965987 uncertain significance Noonan syndrome no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.